AYTU BIOPHARMA, INC cotiza a 1.99 USD y tiene una capitalización bursátil de $22M. En los últimos 12 meses ha facturado $58M con un margen de flujo de caja libre del 5.7%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets f…
| Periodo | 2026-09 | 2026-05 | 2026-02 | 2025-11 |
|---|---|---|---|---|
| Real | $-0.06 | $-0.41 | $-0.23 | $-0.09 |
| Estimado | $-0.35 | $-0.42 | $-0.49 | $-0.19 |
| Sorpresa | +82.9% | +2.4% | +53.1% | +52.6% |
| Métrica | AYTU | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 64.0% | 57.0% | +6.9% |
| Operating Margin | -14.4% | -38.6% | +24.2% |
| Net Margin | -24.8% | -33.6% | +8.8% |
| FCF Margin | 5.7% | -13.9% | +19.5% |
| ROE | -40.4% | -40.4% | 0.0% |
| ROA | -13.6% | -32.0% | +18.4% |
| Current Ratio | 1.13 | 2.84 | -1.71 |
| Debt / Equity | 0.26 | 0.28 | -0.02 |